13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001833486
Total reported value
$88.1M
$88.1M
5 檔
94.0%
During the Q4 2025 filing period, Column Group LLC (CIK: 0001833486) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $88.1M across 5 reported positions.
During Q4 2025, Column Group LLC performed routine portfolio adjustments (0 new buys, 1 additions, 1 trims, and 0 full exits), keeping overall allocation balanced.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Surrozen, Inc. | Stock-Other | 50.54% | +1.01% | +23.44% | |
| 2 | ORIC | Oric Pharmaceuticals Inc | Stock-Other | 34.98% | -1.02% | — | |
| 3 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 8.08% | — | — | |
| 4 | ✓ | Rapt Therapeutics Inc | Stock-Other | 6.39% | — | -5.90% | |
| 5 | RVMD | Revolution Medicines Inc | Stock-Healthcare | — | +0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Surrozen, Inc. | +26.7% | +23.44% | Add |
| 2 | ✓ | Rapt Therapeutics Inc | +1.1% | -5.90% | Trim |
| 3 | RVMD | Revolution Medicines Inc | — | — | Unchanged |
| 4 | TNYA | Tenaya Therapeutics Inc | -10.3% | — | Unchanged |
| 5 | ORIC | Oric Pharmaceuticals Inc | -17.5% | — | Unchanged |
According to official SEC Form 13F filings, Column Group LLC reported a total U.S. public equity portfolio value of $88.1M across 5 disclosed positions in Q4 2025.
During Q4 2025, Column Group LLC's top holdings by market value included Surrozen, Inc. (50.5%)、ORIC (35.0%)、TNYA (8.1%). The largest single position, Surrozen, Inc., represented 50.5% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including Surrozen, Inc., ORIC, TNYA) accounted for 94.0% of total reported equity market value during Q4 2025.
Top Position Liquidated / Trimmed
RAPT THERAPEUTICS INC
前期市值: $4.3M
In Q4 2025, Column Group LLC made 2 total portfolio adjustments, initiating 0 new buys, adding to 1 positions, trimming 1 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.